The change will allow Medicare beneficiaries access to certain GLP-1 medications "outside of the Medicare Part D benefit coverage and payment flow," CMS said
The Danish drugmaker Novo Nordisks value has swollen so much amid the weight loss drug boom that it is dominating, and even distorting, Denmarks economy
Incidence of evolution to lentigo maligna melanoma is low, about 2.2% to 5% in elderly patients
The documented criteria for Mounjaro are: confirmed T2D diagnosis (ICD-10 E11.x), A1c of 6.5% or greater within approximately 90 days, and a documented trial or failure of metformin (plus often one additional oral agent)
If you have been turned away by other providers due to BMI requirements, Belle Health no-BMI-requirement policy means you can still access treatment
The world is finally acknowledging that we have an overweight problem